Darren H. Wakefield

1.3k citations

10 papers · 997 indexed · 1 hit paper · h-index 9

Co-authors: David B. Rozema Jason J. Klein David L. Lewis Qili Chu So C. Wong Jon A. Wolff Andrei V. Blokhin Stephanie Bertin
Topics: RNA Interference and Gene Delivery (7 papers)Advanced biosensing and bioanalysis techniques (4 papers)Virus-based gene therapy research (2 papers)
Cited by: Cancer Research Molecular Biology Hepatology
Journals: Proceedings of the National Academy of Sciences Nucleic Acids Research Circulation
Partner nations: United States Switzerland Germany

In The Last Decade

Darren H. Wakefield

10 papers receiving 949 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Dynamic PolyConjugates for targeted in vivo delivery of siRNA to hepatocytes

2007 523 citations David B. Rozema, David L. Lewis et al. Proceedings of the National Academy of Sciences profile →

Peers

Countries citing papers authored by Darren H. Wakefield

Since Specialization

Citations

This map shows the geographic impact of Darren H. Wakefield's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Darren H. Wakefield with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Darren H. Wakefield more than expected).

Fields of papers citing papers by Darren H. Wakefield

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Darren H. Wakefield. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Darren H. Wakefield. The network helps show where Darren H. Wakefield may publish in the future.

Co-authorship network of co-authors of Darren H. Wakefield

This figure shows the co-authorship network connecting the top 25 collaborators of Darren H. Wakefield. A scholar is included among the top collaborators of Darren H. Wakefield based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Darren H. Wakefield. Darren H. Wakefield is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work	Indexed citations
1	HIF2α-Targeted RNAi Therapeutic Inhibits Clear Cell Renal Cell Carcinoma 2017 ·Molecular Cancer Therapeutics ·So C. Wong,Weijun Cheng,Holly Hamilton,(unknown),Darren H. Wakefield,(unknown),Andrei V. Blokhin,Jeffrey Carlson,Zane C. Neal,Владимир Субботин,Guofeng Zhang,Julia Hegge,Stephanie Bertin,Vladimir S. Trubetskoy,David B. Rozema,David L. Lewis,Steven B. Kanner	27
2	Abstract 17167: Targeting Apolipoprotein(a) With a Novel RNAi Delivery Platform as a Prophylactic Treatment to Reduce Risk of Cardiovascular Events in Individuals With Elevated Lipoprotein (a) 2016 ·Circulation ·Stacey Melquist,Darren H. Wakefield,Holly Hamilton,(unknown),(unknown),Casi M. Schienebeck,(unknown),(unknown),(unknown),(unknown),Julia Hegge,Qili Chu,Vladimir S. Trubetskoy,(unknown),Jane Hoover‐Plow,David B. Rozema,David Lewis,Steven B. Kanner	7
3	Phosphorylation-specific status of RNAi triggers in pharmacokinetic and biodistribution analyses 2016 ·Nucleic Acids Research ·Vladimir S. Trubetskoy,Jacob B. Griffin,(unknown),(unknown),(unknown),Ryan M. Peterson,Christine I. Wooddell,David B. Rozema,Darren H. Wakefield,David L. Lewis,Steven B. Kanner	15
4	Protease-triggered siRNA delivery vehicles 2015 ·Journal of Controlled Release ·David B. Rozema,Andrei V. Blokhin,Darren H. Wakefield,(unknown),Jeffrey Carlson,Jason J. Klein,(unknown),(unknown),Holly Hamilton,Qili Chu,Julia Hegge,So C. Wong,Vladimir S. Trubetskoy,(unknown),Eric Kitas,Jon A. Wolff,David L. Lewis	31
5	Hepatocyte-targeted RNAi Therapeutics for the Treatment of Chronic Hepatitis B Virus Infection 2013 ·Molecular Therapy ·Christine I. Wooddell,David B. Rozema,Markus Hoßbach,Matthias John,Holly Hamilton,Qili Chu,Julia Hegge,Jason J. Klein,Darren H. Wakefield,Claudia E. Oropeza,Jochen Deckert,Ingo Roehl,Kerstin Jahn‐Hofmann,Philipp Hadwiger,(unknown),A. McLachlan,David L. Lewis	241
6	Co-Injection of a Targeted, Reversibly Masked Endosomolytic Polymer Dramatically Improves the Efficacy of Cholesterol-Conjugated Small Interfering RNAs In Vivo 2012 ·Nucleic Acid Therapeutics ·So C. Wong,Jason J. Klein,Holly Hamilton,Qili Chu,(unknown),Vladimir S. Trubetskoy,Julia Hegge,Darren H. Wakefield,David B. Rozema,David L. Lewis	86
7	Dynamic PolyConjugates for targeted in vivo delivery of siRNA to hepatocytesbreakdown → 2007 ·Proceedings of the National Academy of Sciences ·David B. Rozema,David L. Lewis,Darren H. Wakefield,So C. Wong,Jason J. Klein,P. Roesch,Stephanie Bertin,(unknown),Qili Chu,Andrei V. Blokhin,James E. Hagstrom,Jon A. Wolff	523
8	Hepatocyte Targeting of Nucleic Acid Complexes and Liposomes by a T7 Phage p17 Peptide 2006 ·Molecular Pharmaceutics ·So C. Wong,Darren H. Wakefield,Jason J. Klein,Sean Monahan,David B. Rozema,David L. Lewis,(unknown),James J. Ludtke,(unknown),Jon A. Wolff	16
9	Membrane Activity and Transfection Ability of Amphipathic Polycations as a Function of Alkyl Group Size 2005 ·Bioconjugate Chemistry ·Darren H. Wakefield,Jason J. Klein,Jon A. Wolff,David B. Rozema	38
10	A New Short Way to Furocoumarins 1996 ·Heterocyclic Communications ·V. F. Traven,(unknown),Т. А. Чибисова,(unknown),(unknown),Darren H. Wakefield	13

About Darren H. Wakefield

Darren H. Wakefield is a scholar working on Cancer Research, Microbiology and Molecular Biology, having authored 10 papers that have together received 997 indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (7 papers), Advanced biosensing and bioanalysis techniques (4 papers) and Virus-based gene therapy research (2 papers). The work is most often cited by research in Cancer Research (218 citations), Molecular Biology (842 citations) and Hepatology (87 citations). Darren H. Wakefield has collaborated with scholars based in United States, Switzerland and Germany. Frequent co-authors include David B. Rozema, Jason J. Klein, David L. Lewis, Qili Chu, So C. Wong, Jon A. Wolff, Andrei V. Blokhin, Stephanie Bertin, P. Roesch and James E. Hagstrom. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Circulation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact